Global Gene Therapy for Inherited Genetic Disorders Market Growth (Status and Outlook) 2025-2031
According to this study, the global Gene Therapy for Inherited Genetic Disorders market size will reach US$ million by 2031.
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy for Inherited Genetic Disorders Industry Forecast” looks at past sales and reviews total world Gene Therapy for Inherited Genetic Disorders sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy for Inherited Genetic Disorders sales for 2025 through 2031. With Gene Therapy for Inherited Genetic Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy for Inherited Genetic Disorders industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy for Inherited Genetic Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy for Inherited Genetic Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy for Inherited Genetic Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy for Inherited Genetic Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy for Inherited Genetic Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy for Inherited Genetic Disorders market by product type, application, key players and key regions and countries.
Segmentation by Type:
In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy for Inherited Genetic Disorders Industry Forecast” looks at past sales and reviews total world Gene Therapy for Inherited Genetic Disorders sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy for Inherited Genetic Disorders sales for 2025 through 2031. With Gene Therapy for Inherited Genetic Disorders sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy for Inherited Genetic Disorders industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy for Inherited Genetic Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy for Inherited Genetic Disorders portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy for Inherited Genetic Disorders market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy for Inherited Genetic Disorders and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy for Inherited Genetic Disorders.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy for Inherited Genetic Disorders market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Eye Disorders
- Hematological Disorders
- Central Nervous System Disorders
- Muscular Disorders
- Others
- Hospital
- Clinic
- Research Institute
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BioMarin Pharmaceutical Inc.
- bluebird bio Inc.
- Novartis AG
- Orchard Therapeutics Plc
- Spark Therapeutics Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy for Inherited Genetic Disorders Market Size (2020-2031)
2.1.2 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy for Inherited Genetic Disorders by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy for Inherited Genetic Disorders Segment by Type
2.2.1 Eye Disorders
2.2.2 Hematological Disorders
2.2.3 Central Nervous System Disorders
2.2.4 Muscular Disorders
2.2.5 Others
2.3 Gene Therapy for Inherited Genetic Disorders Market Size by Type
2.3.1 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy for Inherited Genetic Disorders Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.4.4 Others
2.5 Gene Therapy for Inherited Genetic Disorders Market Size by Application
2.5.1 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
3 GENE THERAPY FOR INHERITED GENETIC DISORDERS MARKET SIZE BY PLAYER
3.1 Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Player
3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy for Inherited Genetic Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY FOR INHERITED GENETIC DISORDERS BY REGION
4.1 Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025)
4.2 Global Gene Therapy for Inherited Genetic Disorders Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
4.4 APAC Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
4.5 Europe Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025)
5.2 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
5.3 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025)
6.2 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
6.3 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY FOR INHERITED GENETIC DISORDERS MARKET FORECAST
10.1 Global Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy for Inherited Genetic Disorders Forecast
10.1.3 APAC Gene Therapy for Inherited Genetic Disorders Forecast
10.1.4 Europe Gene Therapy for Inherited Genetic Disorders Forecast
10.1.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Forecast
10.2 Americas Gene Therapy for Inherited Genetic Disorders Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy for Inherited Genetic Disorders Forecast
10.2.2 Canada Market Gene Therapy for Inherited Genetic Disorders Forecast
10.2.3 Mexico Market Gene Therapy for Inherited Genetic Disorders Forecast
10.2.4 Brazil Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3 APAC Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.3.1 China Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3.2 Japan Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.3 Korea Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.4 Southeast Asia Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.5 India Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.6 Australia Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4 Europe Gene Therapy for Inherited Genetic Disorders Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.2 France Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.3 UK Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.4 Italy Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.5 Russia Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5.2 South Africa Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5.3 Israel Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5.4 Turkey Market Gene Therapy for Inherited Genetic Disorders Forecast
10.6 Global Gene Therapy for Inherited Genetic Disorders Forecast by Type (2026-2031)
10.7 Global Gene Therapy for Inherited Genetic Disorders Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy for Inherited Genetic Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Information
11.1.2 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 BioMarin Pharmaceutical Inc. Main Business Overview
11.1.5 BioMarin Pharmaceutical Inc. Latest Developments
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Information
11.2.2 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 bluebird bio Inc. Main Business Overview
11.2.5 bluebird bio Inc. Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Gene Therapy for Inherited Genetic Disorders Product Offered
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Information
11.4.2 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Offered
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Orchard Therapeutics Plc Main Business Overview
11.4.5 Orchard Therapeutics Plc Latest Developments
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Information
11.5.2 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Spark Therapeutics Inc. Main Business Overview
11.5.5 Spark Therapeutics Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy for Inherited Genetic Disorders Market Size (2020-2031)
2.1.2 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy for Inherited Genetic Disorders by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy for Inherited Genetic Disorders Segment by Type
2.2.1 Eye Disorders
2.2.2 Hematological Disorders
2.2.3 Central Nervous System Disorders
2.2.4 Muscular Disorders
2.2.5 Others
2.3 Gene Therapy for Inherited Genetic Disorders Market Size by Type
2.3.1 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy for Inherited Genetic Disorders Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.4.4 Others
2.5 Gene Therapy for Inherited Genetic Disorders Market Size by Application
2.5.1 Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
3 GENE THERAPY FOR INHERITED GENETIC DISORDERS MARKET SIZE BY PLAYER
3.1 Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Player
3.1.1 Global Gene Therapy for Inherited Genetic Disorders Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy for Inherited Genetic Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY FOR INHERITED GENETIC DISORDERS BY REGION
4.1 Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025)
4.2 Global Gene Therapy for Inherited Genetic Disorders Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
4.4 APAC Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
4.5 Europe Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025)
5.2 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
5.3 Americas Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025)
6.2 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
6.3 APAC Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025)
7.2 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY FOR INHERITED GENETIC DISORDERS MARKET FORECAST
10.1 Global Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy for Inherited Genetic Disorders Forecast
10.1.3 APAC Gene Therapy for Inherited Genetic Disorders Forecast
10.1.4 Europe Gene Therapy for Inherited Genetic Disorders Forecast
10.1.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Forecast
10.2 Americas Gene Therapy for Inherited Genetic Disorders Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy for Inherited Genetic Disorders Forecast
10.2.2 Canada Market Gene Therapy for Inherited Genetic Disorders Forecast
10.2.3 Mexico Market Gene Therapy for Inherited Genetic Disorders Forecast
10.2.4 Brazil Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3 APAC Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.3.1 China Gene Therapy for Inherited Genetic Disorders Market Forecast
10.3.2 Japan Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.3 Korea Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.4 Southeast Asia Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.5 India Market Gene Therapy for Inherited Genetic Disorders Forecast
10.3.6 Australia Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4 Europe Gene Therapy for Inherited Genetic Disorders Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.2 France Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.3 UK Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.4 Italy Market Gene Therapy for Inherited Genetic Disorders Forecast
10.4.5 Russia Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5.2 South Africa Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5.3 Israel Market Gene Therapy for Inherited Genetic Disorders Forecast
10.5.4 Turkey Market Gene Therapy for Inherited Genetic Disorders Forecast
10.6 Global Gene Therapy for Inherited Genetic Disorders Forecast by Type (2026-2031)
10.7 Global Gene Therapy for Inherited Genetic Disorders Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy for Inherited Genetic Disorders Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioMarin Pharmaceutical Inc.
11.1.1 BioMarin Pharmaceutical Inc. Company Information
11.1.2 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 BioMarin Pharmaceutical Inc. Main Business Overview
11.1.5 BioMarin Pharmaceutical Inc. Latest Developments
11.2 bluebird bio Inc.
11.2.1 bluebird bio Inc. Company Information
11.2.2 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 bluebird bio Inc. Main Business Overview
11.2.5 bluebird bio Inc. Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Gene Therapy for Inherited Genetic Disorders Product Offered
11.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Orchard Therapeutics Plc
11.4.1 Orchard Therapeutics Plc Company Information
11.4.2 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Offered
11.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Orchard Therapeutics Plc Main Business Overview
11.4.5 Orchard Therapeutics Plc Latest Developments
11.5 Spark Therapeutics Inc.
11.5.1 Spark Therapeutics Inc. Company Information
11.5.2 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
11.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Spark Therapeutics Inc. Main Business Overview
11.5.5 Spark Therapeutics Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy for Inherited Genetic Disorders Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Eye Disorders
Table 4. Major Players of Hematological Disorders
Table 5. Major Players of Central Nervous System Disorders
Table 6. Major Players of Muscular Disorders
Table 7. Major Players of Others
Table 8. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Table 11. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Table 14. Global Gene Therapy for Inherited Genetic Disorders Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player (2020-2025)
Table 16. Gene Therapy for Inherited Genetic Disorders Key Players Head office and Products Offered
Table 17. Gene Therapy for Inherited Genetic Disorders Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Table 22. Global Gene Therapy for Inherited Genetic Disorders Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country (2020-2025)
Table 26. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Table 28. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Table 30. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Table 32. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country (2020-2025)
Table 36. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Gene Therapy for Inherited Genetic Disorders
Table 42. Key Market Challenges & Risks of Gene Therapy for Inherited Genetic Disorders
Table 43. Key Industry Trends of Gene Therapy for Inherited Genetic Disorders
Table 44. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. BioMarin Pharmaceutical Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 49. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 50. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. BioMarin Pharmaceutical Inc. Main Business
Table 52. BioMarin Pharmaceutical Inc. Latest Developments
Table 53. bluebird bio Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 54. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 55. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. bluebird bio Inc. Main Business
Table 57. bluebird bio Inc. Latest Developments
Table 58. Novartis AG Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 59. Novartis AG Gene Therapy for Inherited Genetic Disorders Product Offered
Table 60. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Novartis AG Main Business
Table 62. Novartis AG Latest Developments
Table 63. Orchard Therapeutics Plc Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 64. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Offered
Table 65. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Orchard Therapeutics Plc Main Business
Table 67. Orchard Therapeutics Plc Latest Developments
Table 68. Spark Therapeutics Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 69. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 70. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Spark Therapeutics Inc. Main Business
Table 72. Spark Therapeutics Inc. Latest Developments
Table 1. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy for Inherited Genetic Disorders Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Eye Disorders
Table 4. Major Players of Hematological Disorders
Table 5. Major Players of Central Nervous System Disorders
Table 6. Major Players of Muscular Disorders
Table 7. Major Players of Others
Table 8. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Table 11. Gene Therapy for Inherited Genetic Disorders Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Table 14. Global Gene Therapy for Inherited Genetic Disorders Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player (2020-2025)
Table 16. Gene Therapy for Inherited Genetic Disorders Key Players Head office and Products Offered
Table 17. Gene Therapy for Inherited Genetic Disorders Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Table 22. Global Gene Therapy for Inherited Genetic Disorders Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country (2020-2025)
Table 26. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Table 28. Americas Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Table 30. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Table 32. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country (2020-2025)
Table 36. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Gene Therapy for Inherited Genetic Disorders
Table 42. Key Market Challenges & Risks of Gene Therapy for Inherited Genetic Disorders
Table 43. Key Industry Trends of Gene Therapy for Inherited Genetic Disorders
Table 44. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Gene Therapy for Inherited Genetic Disorders Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. BioMarin Pharmaceutical Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 49. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 50. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. BioMarin Pharmaceutical Inc. Main Business
Table 52. BioMarin Pharmaceutical Inc. Latest Developments
Table 53. bluebird bio Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 54. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 55. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. bluebird bio Inc. Main Business
Table 57. bluebird bio Inc. Latest Developments
Table 58. Novartis AG Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 59. Novartis AG Gene Therapy for Inherited Genetic Disorders Product Offered
Table 60. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Novartis AG Main Business
Table 62. Novartis AG Latest Developments
Table 63. Orchard Therapeutics Plc Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 64. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Offered
Table 65. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Orchard Therapeutics Plc Main Business
Table 67. Orchard Therapeutics Plc Latest Developments
Table 68. Spark Therapeutics Inc. Details, Company Type, Gene Therapy for Inherited Genetic Disorders Area Served and Its Competitors
Table 69. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Offered
Table 70. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Spark Therapeutics Inc. Main Business
Table 72. Spark Therapeutics Inc. Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy for Inherited Genetic Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy for Inherited Genetic Disorders Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy for Inherited Genetic Disorders Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy for Inherited Genetic Disorders Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type in 2024
Figure 10. Gene Therapy for Inherited Genetic Disorders in Hospital
Figure 11. Global Gene Therapy for Inherited Genetic Disorders Market: Hospital (2020-2025) & ($ millions)
Figure 12. Gene Therapy for Inherited Genetic Disorders in Clinic
Figure 13. Global Gene Therapy for Inherited Genetic Disorders Market: Clinic (2020-2025) & ($ millions)
Figure 14. Gene Therapy for Inherited Genetic Disorders in Research Institute
Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market: Research Institute (2020-2025) & ($ millions)
Figure 16. Gene Therapy for Inherited Genetic Disorders in Others
Figure 17. Global Gene Therapy for Inherited Genetic Disorders Market: Others (2020-2025) & ($ millions)
Figure 18. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2024
Figure 19. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player in 2024
Figure 20. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Figure 21. Americas Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 22. APAC Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 23. Europe Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 25. Americas Gene Therapy for Inherited Genetic Disorders Value Market Share by Country in 2024
Figure 26. United States Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region in 2024
Figure 31. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Figure 32. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Figure 33. China Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 37. India Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country in 2024
Figure 40. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Figure 41. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Figure 42. Germany Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 43. France Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 56. APAC Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 57. Europe Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 59. United States Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 60. Canada Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 61. Mexico Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 62. Brazil Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 63. China Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 64. Japan Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 65. Korea Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 67. India Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 68. Australia Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 69. Germany Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 70. France Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 71. UK Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 72. Italy Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 73. Russia Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 74. Egypt Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 75. South Africa Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 76. Israel Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 77. Turkey Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 78. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 1. Gene Therapy for Inherited Genetic Disorders Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy for Inherited Genetic Disorders Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy for Inherited Genetic Disorders Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy for Inherited Genetic Disorders Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy for Inherited Genetic Disorders Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type in 2024
Figure 10. Gene Therapy for Inherited Genetic Disorders in Hospital
Figure 11. Global Gene Therapy for Inherited Genetic Disorders Market: Hospital (2020-2025) & ($ millions)
Figure 12. Gene Therapy for Inherited Genetic Disorders in Clinic
Figure 13. Global Gene Therapy for Inherited Genetic Disorders Market: Clinic (2020-2025) & ($ millions)
Figure 14. Gene Therapy for Inherited Genetic Disorders in Research Institute
Figure 15. Global Gene Therapy for Inherited Genetic Disorders Market: Research Institute (2020-2025) & ($ millions)
Figure 16. Gene Therapy for Inherited Genetic Disorders in Others
Figure 17. Global Gene Therapy for Inherited Genetic Disorders Market: Others (2020-2025) & ($ millions)
Figure 18. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application in 2024
Figure 19. Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share by Player in 2024
Figure 20. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Figure 21. Americas Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 22. APAC Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 23. Europe Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size 2020-2025 ($ millions)
Figure 25. Americas Gene Therapy for Inherited Genetic Disorders Value Market Share by Country in 2024
Figure 26. United States Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region in 2024
Figure 31. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Figure 32. APAC Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Figure 33. China Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 37. India Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Country in 2024
Figure 40. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Figure 41. Europe Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Figure 42. Germany Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 43. France Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Gene Therapy for Inherited Genetic Disorders Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 56. APAC Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 57. Europe Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 59. United States Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 60. Canada Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 61. Mexico Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 62. Brazil Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 63. China Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 64. Japan Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 65. Korea Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 67. India Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 68. Australia Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 69. Germany Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 70. France Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 71. UK Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 72. Italy Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 73. Russia Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 74. Egypt Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 75. South Africa Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 76. Israel Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 77. Turkey Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
Figure 78. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Gene Therapy for Inherited Genetic Disorders Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Gene Therapy for Inherited Genetic Disorders Market Size 2026-2031 ($ millions)
More Publications
Global Gene Therapy in Oncology Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
154 pages
Global Gene Therapy for CNS Disorders Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
75 pages
Global Animal Genetics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
April 2025
115 pages
Global Therapy Management Software Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
122 pages
Global Uterine Cancer Therapies and Diagnostic Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
71 pages
